Header cover image

U.K. (FTSE) Biotech Industry Analysis

UpdatedDec 05, 2023
DataAggregated Company Financials
Companies33
  • 7D-3.7%
  • 3M-13.9%
  • 1Y-28.3%
  • YTD-29.4%

Over the last 7 days, the Biotech industry has dropped 3.7%, driven by Genus declining 5.9%. However, the industry is down 28% over the past year. Earnings are forecast to grow by 25% annually.

Industry Valuation and Performance

Has the U.K. Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 05 Dec 2023UK£6.1bUK£1.3b-UK£245,593,375.0035.9x-24.8x4.8x
Thu, 02 Nov 2023UK£6.4bUK£1.3b-UK£253,202,633.0038.3x-25.1x5x
Sat, 30 Sep 2023UK£6.5bUK£1.3b-UK£250,878,408.0038x-26.1x5.1x
Mon, 28 Aug 2023UK£6.6bUK£1.3b-UK£208,561,944.0023.6x-31.6x5.2x
Wed, 26 Jul 2023UK£6.9bUK£1.3b-UK£208,349,483.0023.9x-33.3x5.5x
Fri, 23 Jun 2023UK£6.8bUK£1.3b-UK£205,222,568.0024.2x-33.3x5.4x
Sun, 21 May 2023UK£6.9bUK£1.3b-UK£206,827,996.0022.9x-33.5x5.5x
Tue, 18 Apr 2023UK£7.2bUK£1.2b-UK£154,677,470.0023.8x-46.8x5.8x
Thu, 16 Mar 2023UK£7.2bUK£1.2b-UK£156,684,206.0025.7x-46.1x5.8x
Sat, 11 Feb 2023UK£7.4bUK£1.2b-UK£147,879,541.0027.7x-50.4x6.4x
Mon, 09 Jan 2023UK£7.6bUK£1.2b-UK£141,315,986.0027.2x-53.6x6.5x
Wed, 07 Dec 2022UK£7.6bUK£1.2b-UK£136,451,152.0024.8x-56x6.6x
Fri, 04 Nov 2022UK£7.3bUK£1.2b-UK£142,610,623.0022.7x-51.4x6.3x
Sun, 02 Oct 2022UK£7.2bUK£1.2b-UK£149,633,118.0026.4x-48.4x6.2x
Tue, 30 Aug 2022UK£7.3bUK£1.1b-UK£145,729,061.0035.8x-50.2x6.6x
Thu, 28 Jul 2022UK£7.2bUK£1.1b-UK£201,406,888.0036.7x-35.5x6.4x
Sat, 25 Jun 2022UK£6.8bUK£1.1b-UK£159,280,553.0036x-42.8x6.1x
Mon, 23 May 2022UK£7.1bUK£1.1b-UK£147,193,892.0037.7x-48.1x6.4x
Wed, 20 Apr 2022UK£7.4bUK£1.1b-UK£91,764,045.0039.9x-81x6.8x
Fri, 18 Mar 2022UK£7.9bUK£1.1b-UK£141,435,497.0034.4x-55.9x7.2x
Sun, 13 Feb 2022UK£8.5bUK£1.1b-UK£119,828,523.0035.9x-71x7.8x
Tue, 11 Jan 2022UK£10.3bUK£1.1b-UK£123,419,631.0051.2x-83.6x9.5x
Thu, 09 Dec 2021UK£11.3bUK£1.1b-UK£121,237,078.0058.2x-92.8x10.4x
Sat, 06 Nov 2021UK£11.9bUK£1.1b-UK£149,860,095.0071.3x-79.6x11x
Mon, 04 Oct 2021UK£11.8bUK£1.1b-UK£148,742,870.0068.6x-79.5x10.7x
Wed, 01 Sep 2021UK£12.7bUK£1.0b-UK£172,541,949.9131.4x-73.4x12.4x
Thu, 08 Jul 2021UK£11.2bUK£1.0b-UK£172,541,949.9130.1x-65x11x
Wed, 31 Mar 2021UK£10.8bUK£1.0b-UK£166,311,048.5231.3x-65x10.6x
Sat, 02 Jan 2021UK£9.7bUK£1.0b-UK£143,856,708.8133.2x-67.1x9.6x
Price to Earnings Ratio

-67.1x


Total Market Cap: UK£9.7bTotal Earnings: -UK£143,856,708.81Total Revenue: UK£1.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Biotech Industry Price to Earnings3Y Average -60.3x20222023
Current Industry PE
  • Investors are pessimistic on the British Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 8.3x is higher than the industry's current PS ratio of 4.8x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 8.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market0.37%
Healthcare2.28%
Biotech-3.67%
Biotech-3.67%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NIOX NIOX GroupUK£0.652.2%
+UK£5.9m
78.3%PE33.8x
ONC Oncimmune HoldingsUK£0.2714.7%
+UK£2.5m
-41.9%PS6.5x
4BB 4basebioUK£5.653.7%
+UK£2.5m
-19.3%PS196.6x
BSFA BSF EnterpriseUK£0.1125.7%
+UK£2.3m
-12.0%PB2x
AREC Arecor TherapeuticsUK£1.902.2%
+UK£1.2m
-24.0%PS17.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

OPTI

UK£0.26

OptiBiotix Health

7D

4.0%

1Y

66.7%

SCLP

UK£0.12

Scancell Holdings

7D

-6.0%

1Y

-49.8%

SBTX

UK£0.16

SkinBioTherapeutics

7D

-15.6%

1Y

-9.7%

ONC

UK£0.27

Oncimmune Holdings

7D

14.7%

1Y

-41.9%

HEMO

UK£0.021

Hemogenyx Pharmaceuticals

7D

-24.6%

1Y

65.4%

SNG

UK£0.08

Synairgen

7D

7.0%

1Y

-58.0%

GNS

UK£19.30

Genus

7D

-5.9%

1Y

-36.8%

FARN

UK£2.60

Faron Pharmaceuticals Oy

7D

-1.9%

1Y

-19.4%

PRTC

UK£1.51

PureTech Health

7D

-5.8%

1Y

-48.8%

ETX

UK£0.09

e-therapeutics

7D

-6.2%

1Y

-58.9%

BSFA

UK£0.11

BSF Enterprise

7D

25.7%

1Y

-12.0%

NIOX

UK£0.65

NIOX Group

7D

2.2%

1Y

78.3%

AREC

UK£1.90

Arecor Therapeutics

7D

2.2%

1Y

-24.0%

AVCT

UK£1.35

Avacta Group

7D

-3.7%

1Y

26.0%

CIZ

UK£0.024

Cizzle Biotechnology Holdings

7D

15.9%

1Y

41.8%

4BB

UK£5.65

4basebio

7D

3.7%

1Y

-19.3%